AMGN
AMGEN INC · Healthcare · Market cap $237.0B
Insiders sold $4.1M net in the last 90 days ·3 sellers, 0 buyers· latest Form 4 filed Aug 13, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$29.3M
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Latest filing
Aug 13, 2026
Khosla Rachna
AMGEN INC (AMGN) has 86 SEC Form 4 filings (125 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Aug 13, 2026.
Inside the rolling window, 6 insiders at AMGEN INC reported no open-market purchases and 10 open-market sales totaling $29.3M. The most active filer is SVP, Business Development Khosla Rachna with 3 filings. Insiders have net sold $25.7M over the trailing 6 months. The most recent open-market filing is a sale of 2,000 shares by SVP, Business Development Khosla Rachna, dated Aug 11, 2026, worth $825K.
- Industry:Drug Manufacturers - General
- CEO:Robert A. Bradway
- Employees:31,500
- HQ:Thousand Oaks, CA, US
- IPO:1983-06-17
| Source | |||||||
|---|---|---|---|---|---|---|---|
Khosla RachnaFirst in 9 months | SVP, Business Development | Sale | 2,000 | $825K | Aug 13 | +4.9% | SEC ↗ |
Khosla RachnaFirst in 9 months | SVP, Business Development | Sale | 1,252 | $521K | Aug 13 | +4.9% | SEC ↗ |
Miller DerekFirst filing | SVP, Human Resources | Sale | 3,890 | $1.6M | Aug 7 | +6.7% | SEC ↗ |
Grygiel Nancy A.First in 3 months | SVP & CCO | Sale | 2,970 | $1.2M | Aug 7 | +6.7% | SEC ↗ |
Grygiel Nancy A.First in 6 months | SVP & CCO | Sale | 1,237 | $400K | May 6 | +32.4% | SEC ↗ |
Santos EstebanFirst filing | EVP, Operations | Sale | 54,792 | $20.8M | Mar 2 | +13.6% | SEC ↗ |
Busch Matthew C.First filing | VP, Finance & CAO | Sale | 1,000 | $376K | Feb 20 | +17.0% | SEC ↗ |
Grygiel Nancy A.First filing | SVP & CCO | Sale | 3,139 | $1.1M | Nov 21 | — | SEC ↗ |
Khosla RachnaFirst filing | SVP, Business Development | Sale | 890 | $299K | Nov 13 | — | SEC ↗ |
Gordon MurdoFirst filing | EVP, Global Commercial Ops | Sale | 6,879 | $2.3M | Nov 13 | — | SEC ↗ |
Earnings: last 7 quarters
Congress trading AMGN 164 all-time
- RRep. David TaylorPurchase$1,001 - $15,0002026-09-22
- RRep. David TaylorSale$1,001 - $15,0002026-08-26
- RRep. David J. TaylorOther$1,001 - $15,0002026-08-25
- DSen. Sheldon WhitehouseSale$1,001 - $15,0002026-08-12
- DSen. Sheldon WhitehouseOther$1,001 - $15,0002026-08-12
- RSen. Tommy TubervilleSale$15,001 - $50,0002025-04-15
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does AMGN have?
AMGEN INC (AMGN) has 86 SEC Form 4 filings (125 transaction rows) in the rolling 365-day window, disclosed by 6 distinct insiders. Most recent filing: Aug 13, 2026.
When was the most recent SEC Form 4 filing for AMGN?
The most recent Form 4 filing for AMGN on Tracefour is dated Aug 13, 2026.
Who is the most active insider at AMGN?
The most active SEC Form 4 filer at AMGN in the rolling window is SVP, Business Development Khosla Rachna, with 3 filings.
What is the net insider flow at AMGN over the last 6 months?
Over the trailing 180 days, insiders at AMGN have net sold $25.7M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at AMGN in the current window?
Inside the rolling window, insiders at AMGN bought $0 and sold $29.3M based on SEC Form 4 filings.
Can I get alerts for AMGN insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at AMGEN INC (AMGN). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
AMGEN INC is in the Healthcare sector.